The TaqMan™ OpenArray™ PGx (Pharmacogenomics) Custom Express Panel is an efficient, easy-to-use OpenArray™ plate for pharmacogenomics applications. The assays were developed to detect polymorphisms in genes encoding drug metabolism enzymes (DMEs) and associated transport proteins through Real-time PCR technology using QuantStudio™ 12K Flex Real–Time PCR System with OpenArray AccuFill System—loads samples into OpenArray plates.
At Elite Clinical Laboratory, we utilize cutting-edge technologies to bring the future of personalized healthcare into today’s clinical practice. One of our most powerful platforms is Next Generation Sequencing (NGS), a revolutionary approach that enables comprehensive analysis of genetic material to uncover disease predispositions with unmatched accuracy and depth.
Our NGS platform is powered by Illumina’s industry-leading Sequencing by Synthesis (SBS) technology — the gold standard in high-throughput genetic analysis. Using V2 targeted enrichment probes and advanced XLEAP-SBS™ chemistry, by Illumina NextSeq 1000 system, we achieve exceptional data quality, sensitivity, and coverage across clinically relevant genes.
At Elite Clinical Laboratory, we utilize cutting-edge technologies to bring the future of personalized healthcare into today’s clinical practice. One of our most powerful platforms is Next Generation Sequencing (NGS), a revolutionary approach that enables comprehensive analysis of genetic material to uncover disease predispositions with unmatched accuracy and depth.
Our NGS platform is powered by Illumina’s industry-leading Sequencing by Synthesis (SBS) technology — the gold standard in high-throughput genetic analysis. Using V2 targeted enrichment probes and advanced XLEAP-SBS™ chemistry, by Illumina NextSeq 1000 system, we achieve exceptional data quality, sensitivity, and coverage across clinically relevant genes.
At Elite Clinical Laboratory, we utilize cutting-edge technologies to bring the future of personalized healthcare into today’s clinical practice. One of our most powerful platforms is Next Generation Sequencing (NGS), a revolutionary approach that enables comprehensive analysis of genetic material to uncover disease predispositions with unmatched accuracy and depth.
Our NGS platform is powered by Illumina’s industry-leading Sequencing by Synthesis (SBS) technology — the gold standard in high-throughput genetic analysis. Using V2 targeted enrichment probes and advanced XLEAP-SBS™ chemistry, by Illumina NextSeq 1000 system, we achieve exceptional data quality, sensitivity, and coverage across clinically relevant genes.
Elite Clinical lab using CFX Maestro software offers several analysis modules, including quantification, melt curve, gene expression, allelic discrimination, and end-point analyses for infectious Diseases.
Elite Clinical Lab using Genotyping software to analyze data generated from genotyping experiments for PGX to analyze genetic variations including SNPs.
We are a CLIA and COLA-accredited laboratory, we prioritize excellence through our comprehensive Quality Control (QC) program. This program is designed to ensure early detection of issues related to instruments, reagents, controls, and operators. By adhering to stringent QC and Quality Assurance (QA) guidelines, we guarantee the reliability and accuracy of patient results. Our commitment to quality not only meets regulatory standards but also fosters trust and confidence in our diagnostic services.